169 related articles for article (PubMed ID: 20096652)
1. MGMT Ile143Val polymorphism, dietary factors and the risk of breast, colorectal and prostate cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Norfolk study.
Loh YH; Mitrou PN; Bowman R; Wood A; Jeffery H; Luben RN; Lentjes MA; Khaw KT; Rodwell SA
DNA Repair (Amst); 2010 Apr; 9(4):421-8. PubMed ID: 20096652
[TBL] [Abstract][Full Text] [Related]
2. SMAD7 and MGMT genotype variants and cancer incidence in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Norfolk Study.
Loh YH; Mitrou PN; Wood A; Luben RN; McTaggart A; Khaw KT; Rodwell SA
Cancer Epidemiol; 2011 Aug; 35(4):369-74. PubMed ID: 21075068
[TBL] [Abstract][Full Text] [Related]
3. MGMT germline polymorphism is associated with somatic MGMT promoter methylation and gene silencing in colorectal cancer.
Ogino S; Hazra A; Tranah GJ; Kirkner GJ; Kawasaki T; Nosho K; Ohnishi M; Suemoto Y; Meyerhardt JA; Hunter DJ; Fuchs CS
Carcinogenesis; 2007 Sep; 28(9):1985-90. PubMed ID: 17621591
[TBL] [Abstract][Full Text] [Related]
4. Polymorphisms in MGMT and DNA repair genes and the risk of esophageal adenocarcinoma.
Doecke J; Zhao ZZ; Pandeya N; Sadeghi S; Stark M; Green AC; Hayward NK; Webb PM; Whiteman DC;
Int J Cancer; 2008 Jul; 123(1):174-80. PubMed ID: 18386788
[TBL] [Abstract][Full Text] [Related]
5. SNP rs16906252C>T Is an Expression and Methylation Quantitative Trait Locus Associated with an Increased Risk of Developing MGMT-Methylated Colorectal Cancer.
Kuroiwa-Trzmielina J; Wang F; Rapkins RW; Ward RL; Buchanan DD; Win AK; Clendenning M; Rosty C; Southey MC; Winship IM; Hopper JL; Jenkins MA; Olivier J; Hawkins NJ; Hitchins MP
Clin Cancer Res; 2016 Dec; 22(24):6266-6277. PubMed ID: 27267851
[TBL] [Abstract][Full Text] [Related]
6. MGMT methylation is associated primarily with the germline C>T SNP (rs16906252) in colorectal cancer and normal colonic mucosa.
Hawkins NJ; Lee JH; Wong JJ; Kwok CT; Ward RL; Hitchins MP
Mod Pathol; 2009 Dec; 22(12):1588-99. PubMed ID: 19734844
[TBL] [Abstract][Full Text] [Related]
7. Genetic association and functional studies of major polymorphic variants of MGMT.
Bugni JM; Han J; Tsai MS; Hunter DJ; Samson LD
DNA Repair (Amst); 2007 Aug; 6(8):1116-26. PubMed ID: 17569599
[TBL] [Abstract][Full Text] [Related]
8. O6-methylguanine-DNA methyltransferase Leu84Phe and Ile143Val polymorphisms and risk of colorectal cancer in the Nurses' Health Study and Physicians' Health Study (United States).
Tranah GJ; Bugni J; Giovannucci E; Ma J; Fuchs C; Hines L; Samson L; Hunter DJ
Cancer Causes Control; 2006 Jun; 17(5):721-31. PubMed ID: 16633920
[TBL] [Abstract][Full Text] [Related]
9. Impact of catechol-O-methyltransferase gene variants on methylation status of P16 and MGMT genes and their downregulation in colorectal cancer.
Wani HA; Majid S; Bhat AA; Amin S; Farooq R; Bhat SA; Naikoo NA; Beigh MA; Kadla SA
Eur J Cancer Prev; 2019 Mar; 28(2):68-75. PubMed ID: 30379684
[TBL] [Abstract][Full Text] [Related]
10. The polymorphisms in the MGMT gene and the risk of cancer: a meta-analysis.
Du L; Wang H; Xiong T; Ma Y; Yang J; Huang J; Zeng D; Wang X; Huang H; Huang J
Tumour Biol; 2013 Oct; 34(5):3227-37. PubMed ID: 23760981
[TBL] [Abstract][Full Text] [Related]
11. MGMT genotype modulates the associations between cigarette smoking, dietary antioxidants and breast cancer risk.
Shen J; Terry MB; Gammon MD; Gaudet MM; Teitelbaum SL; Eng SM; Sagiv SK; Neugut AI; Santella RM
Carcinogenesis; 2005 Dec; 26(12):2131-7. PubMed ID: 16014702
[TBL] [Abstract][Full Text] [Related]
12. Refining the selection of patients with metastatic colorectal cancer for treatment with temozolomide using proteomic analysis of O6-methylguanine-DNA-methyltransferase.
Schwartz S; Szeto C; Tian Y; Cecchi F; Corallo S; Calegari MA; Di Bartolomeo M; Morano F; Raimondi A; Fucà G; Martinetti A; De Pascalis I; Martini M; Belfiore A; Milione M; Orlandi A; Barault L; Barone C; de Braud F; Di Nicolantonio F; Benz S; Hembrough T; Pietrantonio F
Eur J Cancer; 2019 Jan; 107():164-174. PubMed ID: 30579113
[TBL] [Abstract][Full Text] [Related]
13. Lipoic acid inhibits the DNA repair protein O 6-methylguanine-DNA methyltransferase (MGMT) and triggers its depletion in colorectal cancer cells with concomitant autophagy induction.
Göder A; Nagel G; Kraus A; Dörsam B; Seiwert N; Kaina B; Fahrer J
Carcinogenesis; 2015 Aug; 36(8):817-31. PubMed ID: 25998848
[TBL] [Abstract][Full Text] [Related]
14. The MGMT promoter SNP rs16906252 is a risk factor for MGMT methylation in glioblastoma and is predictive of response to temozolomide.
Rapkins RW; Wang F; Nguyen HN; Cloughesy TF; Lai A; Ha W; Nowak AK; Hitchins MP; McDonald KL
Neuro Oncol; 2015 Dec; 17(12):1589-98. PubMed ID: 25910840
[TBL] [Abstract][Full Text] [Related]
15. Kras gene mutation and RASSF1A, FHIT and MGMT gene promoter hypermethylation: indicators of tumor staging and metastasis in adenocarcinomatous sporadic colorectal cancer in Indian population.
Sinha R; Hussain S; Mehrotra R; Kumar RS; Kumar K; Pande P; Doval DC; Basir SF; Bharadwaj M
PLoS One; 2013; 8(4):e60142. PubMed ID: 23573237
[TBL] [Abstract][Full Text] [Related]
16. DNA repair polymorphisms XRCC1 and MGMT and risk of adult gliomas.
Felini MJ; Olshan AF; Schroeder JC; North KE; Carozza SE; Kelsey KT; Liu M; Rice T; Wiencke JK; Wrensch MR
Neuroepidemiology; 2007; 29(1-2):55-8. PubMed ID: 17898525
[TBL] [Abstract][Full Text] [Related]
17. MGMT and MLH1 promoter methylation versus APC, KRAS and BRAF gene mutations in colorectal cancer: indications for distinct pathways and sequence of events.
de Vogel S; Weijenberg MP; Herman JG; Wouters KA; de Goeij AF; van den Brandt PA; de Bruïne AP; van Engeland M
Ann Oncol; 2009 Jul; 20(7):1216-22. PubMed ID: 19164452
[TBL] [Abstract][Full Text] [Related]
18. The L84F polymorphism in the O6-Methylguanine-DNA-Methyltransferase (MGMT) gene is associated with increased hypoxanthine phosphoribosyltransferase (HPRT) mutant frequency in lymphocytes of tobacco smokers.
Hill CE; Wickliffe JK; Guerin AT; Kinslow CJ; Wolfe KJ; Ammenheuser MM; Abdel-Rahman SZ
Pharmacogenet Genomics; 2007 Sep; 17(9):743-53. PubMed ID: 17700363
[TBL] [Abstract][Full Text] [Related]
19. Assessment of Quantitative and Allelic MGMT Methylation Patterns as a Prognostic Marker in Glioblastoma.
Kristensen LS; Michaelsen SR; Dyrbye H; Aslan D; Grunnet K; Christensen IJ; Poulsen HS; Grønbæk K; Broholm H
J Neuropathol Exp Neurol; 2016 Mar; 75(3):246-55. PubMed ID: 26883115
[TBL] [Abstract][Full Text] [Related]
20. The T genotype of the MGMT C>T (rs16906252) enhancer single-nucleotide polymorphism (SNP) is associated with promoter methylation and longer survival in glioblastoma patients.
McDonald KL; Rapkins RW; Olivier J; Zhao L; Nozue K; Lu D; Tiwari S; Kuroiwa-Trzmielina J; Brewer J; Wheeler HR; Hitchins MP
Eur J Cancer; 2013 Jan; 49(2):360-8. PubMed ID: 22975219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
